SCHEMBL13675027

SCHEMBL13675027

COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)CCCC(N)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)C(C)O1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.79
▸ THRB P10828 8/20 0.79
▸ KMT2A Q03164 8/20 0.79
▸ RECQL P46063 6/20 0.79
▸ BLM P54132 6/20 0.79
▸ HIF1A Q16665 6/20 0.79
▸ SMN1; SMN2 Q16637 6/20 0.79
▸ BRCA1 P38398 6/20 0.79
▸ TDP1 Q9NUW8 5/20 0.79
▸ MAPT P10636 5/20 0.79
▸ TOP2A P11388 4/20 0.79
▸ MAPK1 P28482 4/20 0.79
▸ STAT6 P42226 4/20 0.79
▸ CHRM1 P11229 3/20 0.79
▸ TBXA2R P21731 3/20 0.79
▸ KDM4E B2RXH2 3/20 0.79
▸ ALDH1A1 P00352 3/20 0.79
▸ ABCB1 P08183 3/20 0.79
▸ HTT P42858 3/20 0.79
▸ FYN P06241 2/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12022418 1.00 MEN1 (0.79) MEN1THRBKMT2ARECQLBLM
SCHEMBL17929839 0.96 MEN1 (0.78) MEN1THRBKMT2ARECQLBLM
SCHEMBL15682452 0.96 MEN1 (0.78) MEN1THRBKMT2ARECQLBLM
SCHEMBL14524965 0.96 MEN1 (0.78) MEN1THRBKMT2ARECQLBLM
SCHEMBL14867452 0.96 MEN1 (0.84) MEN1THRBKMT2ARECQLBLM
SCHEMBL31237938 0.94 MEN1 (0.77) MEN1THRBKMT2ARECQLBLM
SCHEMBL10138466 0.94 MEN1 (0.81) MEN1THRBKMT2ARECQLBLM
SCHEMBL16015696 0.93 MEN1 (0.80) MEN1THRBKMT2ARECQLBLM
SCHEMBL26387964 0.93 MEN1 (0.80) MEN1THRBKMT2ARECQLBLM
SCHEMBL12462937 0.93 MEN1 (0.80) MEN1THRBKMT2ARECQLBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7608591-B2 Prodrug comprising cytosine arabinoside or doxorubicin linked to legumain peptide substrate having peptide consisting of amino acid sequence Ala-Ala-Asn-Leu where legumain cleaves peptide at link between Asn and other amino acid to generate active cytosine arabinoside or doxorubicin from prodrug; cancer THE SCRIPPS RESEARCH INSTITUTE (US) 2009-10-27 — — US disclosed
Send feedback